Frontiers in Neurology (Sep 2024)

Systematic review of photobiomodulation for multiple sclerosis

  • Vander Oliveira de Andrade Filho,
  • Marina Oliveira Coura Amarante,
  • Francisco Gonzalez-Lima,
  • Sérgio Gomes da Silva,
  • Sérgio Gomes da Silva,
  • Sérgio Gomes da Silva,
  • Fabrízio dos Santos Cardoso,
  • Fabrízio dos Santos Cardoso

DOI
https://doi.org/10.3389/fneur.2024.1465621
Journal volume & issue
Vol. 15

Abstract

Read online

BackgroundMultiple sclerosis (MS) is an inflammatory chronic autoimmune and neurodegenerative disorder of the brain and spinal cord, resulting in loss of motor, sensorial, and cognitive function. Among the non-pharmacological interventions for several brain conditions, photobiomodulation (PBM) has gained attention in medical society for its neuroprotective effects. We systematically reviewed the effects of PBM on MS.MethodsWe conducted a systematic search on the bibliographic databases (PubMed and ScienceDirect) with the keywords based on MeSH terms: PBM, low-level laser therapy, multiple sclerosis, autoimmune encephalomyelitis, demyelination, and progressive multiple sclerosis. Data search was limited from 2012 to July 2024. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The initial systematic search identified 126 articles. Of these, 68 articles were removed by duplicity and 50 by screening. Thus, 8 studies satisfied the inclusion criteria.ResultsThe reviewed studies showed that PBM modulates brain markers linked to inflammation, oxidative stress, and apoptosis. Improvements in motor, sensorial, and cognitive functions in MS patients were also observed after PBM therapy. No study reported adverse effects of PBM.ConclusionThese findings suggest the potential of PBM as a promising non-pharmacological intervention for the management of MS, although further research is needed to standardize PBM protocols and assess its long-term effects.

Keywords